A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

MLA

Turro, Ernest, et al. “A Dominant Gain-of-Function Mutation in Universal Tyrosine Kinase SRC Causes Thrombocytopenia, Myelofibrosis, Bleeding, and Bone Pathologies.” Science Translational Medicine, vol. 8, no. 328, Mar. 2016, pp. 1–15. EBSCOhost, https://doi.org/10.1126/scitranslmed.aad7666.

APA

Turro, E., Greene, D., Wijgaerts, A., Thys, C., Lentaigne, C., Bariana, T. K., Westbury, S. K., Kelly, A. M., Selleslag, D., Stephens, J. C., Papadia, S., Simeoni, I., Penkett, C. J., Ashford, S., Attwood, A., Austin, S., Bakchoul, T., Collins, P., Deevi, S. V. V., & Favier, R. (2016). A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies. Science Translational Medicine, 8(328), 1–15. https://doi.org/10.1126/scitranslmed.aad7666

Chicago

Turro, Ernest, Daniel Greene, Anouck Wijgaerts, Chantal Thys, Claire Lentaigne, Tadbir K. Bariana, Sarah K. Westbury, et al. 2016. “A Dominant Gain-of-Function Mutation in Universal Tyrosine Kinase SRC Causes Thrombocytopenia, Myelofibrosis, Bleeding, and Bone Pathologies.” Science Translational Medicine 8 (328): 1–15. doi:10.1126/scitranslmed.aad7666.